Romlọ nke TromboMag® (TromboMag)

Ọgwụ a na-egbochi ọrụ cyclooxygenases 1 na 2, nke na-ekere òkè na nhazi nke njikọta prostaglandin (na-akpata ọzịza ma na-etolite ọrịa mgbu).

Mbadamba mkpụrụ osisi nke Thrombopol nwere analgesic, anti-inflammatory, antipyretic.

Akụkụ nọ n'ọrụ bụ acetylsalicylic acid.

Mbelata nke prostaglandins na thermoregulation etiti na-ebute mbelata nke ahụ ọkụ n'ihi mmụba ọsụsọ na mmebi ahụ nke akpụkpọ ahụ na - emegharị ọnụ. N'ihi nsonaazụ etiti na nke akụkụ nke ihe mejupụtara akụkụ ahụ, a na-enweta mmetụta analgesic.

Ọgwụ na-ebelata ọrụ thrombosis n'ihi mmechi nke njikọta nke thromboxane A2 n'ime sel ọbara site na platelet. Ọgwụ na-akwụsịlata mgbasa na nchịkọta nke platelet.

Emeri na enyemaka nke ọgwụ Thrombopol (otu dose) mmetụta antiplatelet zọpụtara ụbọchị 7. N'ime ndị ọrịa nwere angina na-akwụghị chịm, ọgwụ ahụ na-ebelata ihe ize ndụ nke infarction myocardial, onwu.

A na-eji ọgwụ ahụ eme ihe maka mgbochi mbụ na nke abụọ nke infarction myocardial.

Kwa ụbọchị nke 6 grams na-abawanye oge prothrombin, gbochie njikọta prothrombin na anụ ahụ.

N'okpuru ọrụ acetylsalicylic acid, a na-agbakọta uche nke ihe coagulation (2,7,9,10), ọrụ plasma fibrinolytic na-abawanye.

N’oge ịwa ahụ, ọgwụ a na-abawanye ugboro ugboro ihe ọgbụgba ọbara, na-eme ka ohere ịmị ọbara dị.

Ọgwụ Thrombopol na-akpali usoro ịtụgharị uche uric acid (usoro nke uric acid reabsorption na akụrụ na-agbagha).

Ihe ngosi maka ojiji

Edere ọgwụ ahụ maka ahụ efe mgbu mgbu (dị nro, agafeghị oke) nke ụzọ dị iche iche: eze mgbu, isi ọwụwa, isi ọwụwa, neuralgia, algodismenorea, radicular syndrome, lumbago, myalgia, arthralgia, isi ọwụwa na wepu ọrịa mmanya.

A na-eji ọgwụ ahụ eme ihe ọrịa febrile megide ndabere nke ọrịa na-efe efe na mkpali.

Ihe ngbanwe

Ntụziaka maka iji thrombopol anaghị atụ aro ịkọpụta ọgwụ maka ekweghị na Acetylsalicylic acid, yana hemorrhagic diathesisọbara ọgbụgba dị n'ọbara, ya na mgbanwe ndị na-egbu ahụ na ọnya akwara na sistemụ na-efe efe na nnukwu ọrịa, na-arịa ụkwara ume ọkụ (ụdị na-akpata salicylates na ọgwụ NSAID), na-eji usoro ọgwụgwọ ahụ n'otu oge. methotrexate na usoro onunu ogwu nke 15 kwa izu ma obu karia.

Edebere mbadamba nkume Thrombopol maka mmegharị ahụ, ebe a na-enye nwa ara. A machibidoro ị inụ ọgwụ ahụ na ụmụaka.

Nsonaazụ

Thrombopol nwere ike ibute ọgbụgbọ, Ọrịa Reye (mmepe nke imeju ọdịda na njikọ ya na nnukwu ọrịa na-aga n'ihu ngwa ngwa imeju abuba na encephalopathy concomitant), mmeghachi omume nfụkasị (n'ụdị nke bronchospasm, angioedema na ọnya anụ ahụ), afọ ọsịsa, anaemia, thrombocytopenia, gastralgia, agụụ belatara, leukopenia.

Ogologo oge ọgwụgwọ nwere ike ibute isi ọwụwa, ọgbụgbọ, ọbara ọgbụgba, hypocoagulation, mbuze na ọnya nke sistem, ọgbụgbọ, bronchospasm, tinnitus, na mbelata na nchepụta auditory, interstitial jade, ọgba aghara a na-ahụ anya, ọzịza, ihe mgbaàmà nke nkụda obi, menyere ọrịa nwoke bidoroọrịa nephrotic syndrome, nnukwu akụrụ gbasara akwara, papillary necrosis, prezoal azotemia tinyere hypercalcemia na hypercreatininemia, mụbara enzymes imeju.

Thrombopol, ntuziaka maka ojiji (Usoro na usoro onunu ogwu)

A na-eji ọnụ ede okwu Thrombopol. A na-eme ka ọgwụ mgbochi mkpali na analgesic pụta site na iji ọgwụ ọjọọ eme ihe karịa 400-500 mg.

Site na mgbu na ọrịa febrile na-ahọpụta 0,5-1 grams kwa ụbọchị (3 doses).

Usoro ọgwụgwọ agaghị agafe izu abụọ. Otu usoro onodu ogwu maka aru oru oma nke ogwu ahu bu 0.25-1 gram (ogwu ato kwa ubochi).

Dodoụbiga ya ókè

Symptomsụbiga ọ symptomsụ ókè: ọgbụgbọ, ọgbụgbọ, iku ume ngwa ngwa, tinnitus, ịnụ ntị na ọhụhụ isi ọwụwa, isi ọwụwa, ụra. N'ihe banyere ihe mejuputara ihe kariri 500 mg kwa n'arọ, o nwere ike ibute ndigbo.

Ghichaa afọ, kpata ọgbụgbọ, were unyi na-arụ ọrụ. Can nweghị ike ị barụ barbiturates. Ọ nweghị ọgwụ mgbochi.

Mmekorita

Thrombopol nwere ike ịkwalite mmetụta na-egbu egbu methotrexatebelata yaikike mkpụkọ.

Ọgwụ a na-akwalite nsonaazụ nke heparin, analgesics narcotic, anticoagulants na-apụtaghị ìhèndị nnọchi anya hypoglycemic, ndị na-ahụ maka ihe mgbochi, thrombolyticssulfonamides.

Acetylsalicylic acid na-ebelata ịdị irè nke ọgwụ nri (furosemide, spironalokton), ọgwụ antihypertensive, ọgwụ uricosuric(sulfinpyrazone, benzbromarone).

Ethanol nwere nkwadebe, ethanol n’onwe ya na glucocorticosteroids mee ka mmetụta ọgwụ ahụ dịkwuo nfe na mucous na akụkụ nke digestive, nke nwere ike ibute ọbara ọgbụgba n'ime.

Thrombopol na-abawanye ọkwa nke barbiturates, digoxin na nnu nke lithium n'ime ọbara.

Ordọ aka na-agbada site n'otu oge antacids.

Ọgwụ ndị dị na Myelotoxic na-akwalite mmetụta hematotoxic nke thrombopol.

Ntụziaka pụrụ iche

Takingzọ ị acụ ọgwụ acetylsalicylic acid iji wee rụpụta ihe nyocha na-enweghị ịgakwuru dọkịta agaghị agafe ụbọchị ise.

Edeghị Thrombopol makaọrịa myocarditis na-efe eferheumatoid ogbu na nkwonkwo, rheumatism, pericarditis na nsogbu ụgbụ.

A na-akagbu ọgwụ ahụ ụbọchị 5-7 tupu oge ịwa ahụ.

Ogologo oge ọgwụgwọ chọrọ nyocha ọbara ọbara ma nyochaa njikwa ọbara.

N'ime ụmụaka, iwere Thrombopol nwere ike ibute ọrịa Reye (mmụba na nha imeju, mmepe nke oge oke encephalopathy, ogologo oge, ọgbụgbọ na-enweghị ike).

N'otu oge, ọgwụ ndị na-egbochi acidity nke ihe ọricụricụ afọ nwere ike belata mmetụta mkpali nke acetylsalicylic acid na mgbidi mucous nke usoro nri.

Thrombopol bụ njirimara Mmetụta teratogenic (mmechi akwara nke ductus arteriosus, nkenke nke okpo ọnụ na mgbanwe ndị ọzọ na mmepe nwa ebu n'afọ).

N'ime ndị ọrịa nwere gout, ọgwụ nwere ike ibute ọgụ dị egwu n'ihi mbelata nke excication uric acid ka na-ewere acetylsalicylic acid.

Isjụ ị drinksụ ihe ọ containingụ alcoholụ na-aba n'anya n'oge oge ọgwụgwọ ahụ dum.

Etu esi eji: usoro onunu ogwu na usoro ọgwụgwọ

N'ime, 1-2 awa mgbe iri nri, 1 oge kwa ụbọchị.

Mbadamba mbadamba maka nkwadebe TromboMag loro kpamkpam (enwere ike ita ata ma obu tuo ya), were mmiri sachaa ya.

O bu n'uche ogwu a ka o jiri ogologo oge. Ọ bụ dọkịta ga-ekpebi oge ọgwụgwọ ọ bụla.

Prophylaxis nke mbu nke ọrịa obi, dịka thrombosis na oke obi ike, na ọnụnọ ihe ndị dị ize ndụ (dịka ọmụmaatụ, ọrịa shuga mellitus, hyperlipidemia, ọbara mgbali elu, oke ibu, ị smokingụ sịga, ịka nká)

N'ụbọchị mbụ - 1 mbadamba ihe nwere 150 mg nke acetylsalicylic acid, mgbe ahụ 1 mbadamba 1 nke nwere 75 mg nke acetylsalicylic acid.

Mbelata infarction myocardial na thrombosis arịa ọbara

Otu mbadamba 1 nke nwere 75 mg ma ọ bụ 150 mg nke acetylsalicylic acid.

Otu mbadamba 1 nke nwere 75 mg ma ọ bụ 150 mg nke acetylsalicylic acid.

Mgbochi nke thromboembolism mgbe akwara vaskụla (dịka ọmụmaatụ akwara ọbara na -akpata ọrịa grafting, percutaneous transluminal coronary angioplasty)

Otu mbadamba 1 nke nwere 75 mg ma ọ bụ 150 mg nke acetylsalicylic acid.

Ọ bụrụ n’ịgha otu ọgwụ ma ọ bụ karịa nke ThromboMag ọgwụ, ị ga-anụrụ ọgwụ echefuru ozugbo onye ọrịa ahụ chetara nke a. Iji zere ịgbanye okpukpu abụọ nke ọgwụ a, ịkwesighi ị were mbadamba ihe furu efu ma ọ bụrụ na oge ị theụ ọgwụ ọzọ na-eru nso.

Achọpụtaghị ihe ndị a na-eme n'oge ọchịchị mbụ ma ọ bụ wepụ ọgwụ ahụ.

Omume ọgwụ

Usoro nke ihe mgbochi antiplatelet nke acetylsalicylic acid (ASA) dabere na mgbochi a na-agbanwe agbanwe nke enzyme cyclooxygenase (COX-1), n'ihi nke a na-egbochi thromboxane A2 njikọ ya ma na-ebelata nchịkọta platelet.

A na-ekwukarị ihe mgbochi mgbochi na platelet, ebe ọ bụ na ha enweghị ike ịmegharị COX. Ekwenyere na ASA nwere usoro ndị ọzọ maka igbochi nchịkọta platelet, nke na-agbasa obosara ya n'ọrịa ọrịa vaskụla dị iche iche. ASA nwekwara ọgwụ mgbochi, antipyretic na ọgwụ analgesic.

Magnesium hydroxide - ọgwụ antacid, na-ebelata ihe iwe iwe nke ASA na mucosa gastric.

Ime na lactation

Ojiji nke salicylates na usoro onyonyo dị elu n'ime ọnwa atọ mbụ nke afọ ime nwere njikọta na-abawanye nke mmerụ imu nwa ebu n'afọ (nkewa nke oke ugwu, ntụpọ obi). N'ime ọgwụ ọnwa mbụ nke afọ ime ka a machibidoro ya iwu. N’ime oge nke abụọ nke ịtụrụ ime, enwere ike inye ọgwụ a ka ọ bụrụ n’inwe nyocha dị omimi banyere uru ọrụ ọgwụgwọ dịịrị nne na ihe ọghọm nwere ike n’aru nwa ebu n’afọ, n’a doụ ihe karịrị 150 mg / ụbọchị n’otu obere oge. N’ime ọnwa atọ nke afọ ime, salicylates n’ime oke ọgwụ (ihe karịrị 300 mg / ụbọchị) na - ebute mgbochi nke ọrụ, mmechi akwara nke ductus arteriosus na nwa ebu n’afọ, ọbara ọgbụgba n’ime nne na nwa n’afọ, na iji ya ozugbo amụ nwa nwere ike ibute ọbara ọgbụgba intracranial, ọkachasị n’oge ụmụ aka. A machiri iji ogwu ahu n’ime ato ato nke ime.

Salicylates na metabolites ha na obere ihe na-abanye n'ime mmiri ara. Data nke ụlọ ọgwụ iji chọpụta nchekwa nke acetylsalicylic acid n'oge inye ara ezughị. Tupu ịkọwa acetylsalicylic acid n'oge a na-enye nwa ara, a ga-enyocha uru atụmatụ ọgwụgwọ ọgwụ na ihe egwu nwere ike ịmụrụ ụmụ ọhụrụ. Usoro a na-anabatakarị nke salicylates n'oge a na-enye nwa na-esoghị mmepe mmeghachi omume ọjọọ na nwatakịrị ahụ anaghị achọ ịkwụsị ị ofụ ara. Agbanyeghị, ọ bụrụ na ịchọrọ iji ọgwụ ogologo oge, ị ga-akwụsị inye nwa ara ozugbo.

Nhazi ọkwa nosological (ICD-10)

Usoro onunu ogwu na nhazi

N'ime 1-2 awa mgbe nri, 1 oge kwa ụbọchị.

Mbadamba mbadamba maka nkwadebe TromboMag ® loda ihe (enwere ike ita ata ma ọ bụ gwerie ya), jiri mmiri sachaa ya.

Ọgwụ TromboMag ® bu n’obi iji ogologo oge. Ọ bụ dọkịta ga-ekpebi oge ọgwụgwọ ọ bụla.

Ihe mgbochi mbu nke oria obi agha, dika nkpuru ogwu na otiti obi, n’iru ihe ndi puru ime (dika oria shuga, hyperlipidemia, obara mgbali elu, oke ibu, anwuru anwu, onwu). N’ụbọchị mbụ - 1 tebụl. ThromboMag ® nkwadebe nwere 150 mg nke acetylsalicylic acid, mgbe ahụ - 1 tebụl. ThromboMag ® nwere 75 mg nke acetylsalicylic acid.

Mgbochi nke infarction myocardial ugboro ugboro na thrombosis arịa ọbara. Taabụ 1. ThromboMag ® nwere 75 ma ọ bụ 150 mg nke acetylsalicylic acid.

Angina pectoris ejisighi ike. Taabụ 1. ThromboMag ® nwere 75 ma ọ bụ 150 mg nke acetylsalicylic acid.

Mgbochi nke thromboembolism mgbe akwara vaskụla (dịka ọmụmaatụ akwara ọbara akwara na -akpọ grafting, percutaneous transluminal coronary angioplasty). Taabụ 1. ThromboMag ® nwere 75 ma ọ bụ 150 mg nke acetylsalicylic acid.

Mgbe ịwụsịrị otu ma ọ bụ karịa usoro nke nkwadebe TromboMag,, ọ dị mkpa ị doseụ ọgwụ echefuru ozugbo onye ọrịa ahụ chetara nke a. Iji zere ịgbanye okpukpu abụọ nke ọgwụ a, ịkwesighi ị were mbadamba ihe furu efu ma ọ bụrụ na oge ị theụ ọgwụ ọzọ na-eru nso.

Achọpụtaghị ihe ndị a na-eme n'oge ọchịchị mbụ ma ọ bụ wepụ ọgwụ ahụ.

Mpempe mwepụta

Mbadamba ihe eji etinye ihe nkiri 75 mg + 15.2 mg ma ọ bụ 150 mg + 30.39 mg. 10 taabụ. na ngwungwu ngwugwu nke ejiri mpempe akwụkwọ nke alumọn e biri ebi na nke a na-eji aluminom mee ya, kọmpụta PVC na ihe nkiri polyamide. A na-etinye blister 3 ma ọ bụ 10 na ngwugwu kaadiboodu.

Emeputa

Hemofarm LLC, Russia. 249030, Kaluga Mpaghara, Obninsk, Kievskoye sh., 62.

Tẹ.: (48439) 90-500, faksị: (48439) 90-525.

Aha na adresị nke ụlọ ọrụ iwu nke aha ya ka enyerela asambodo ndenye / nzukọ na-anabata nnabata. Nizhpharm JSC, Russia, 603950, Nizhny Novgorod, GSP-459, ul. Salgan, 7.

Ekwentị: (831) 278-80-88, faksị: (831) 430-72-28.

Mlọ ọgwụ

Ozugbo n'ime eriri afọ, ASA na-abanye ngwa ngwa na ọ fọrọ nke nta ka ọ bụrụ kpamkpam. Na ntinye n'otu oge, itinye uche na-akwụsịlata. Ọ na-enwe metabolism dị ala n'oge ịmịkọrọ.

N'oge na mgbe ịmachara ya, a na-emegharị ASA n'ime metabolite nke bụ isi - salicylic acid, nke a na-emetụtakwa n'okpuru ike nke enzyme (nke kachasị na imeju), na-ebute nguzobe metabolites dịka salicylic acid, glucuronide salicylate na phenyl salicylate, nke a na-ahụ n'ọtụtụ mmiri na akwara. N'ime ụmụ nwanyị, ASA metabolism dị nwayọ (n'ihi ọrụ dị ala nke enzymes na serum).

Oke plasma ịta nke ASA ruru nkeji 10-20 mgbe ịwere ThromboMag ọnụ, salicylic acid - nkeji 18-120. Acetylsalicylic na salicylic acid na-ejikọ akwa protein na plasma ma na-ekesa ngwa ngwa. Njikọ nke salicylic acid na protein ndị na-enye plasma abụghị ahịrị, ọ dabere na ịta. Na ntinye dị ala (0.4 mg / ml) - ruru 75%.

Otito nke acetylsalicylic acid bu 50-68%, salicylic acid - 80-100%. Acid Salicylic na-agafe ihe mgbochi placental ma banye n’ime mmiri ara.

N'ime ụmụ amụrụ ọhụrụ, ụmụ nwanyị dị ime, na ndị ọrịa nwere ọrịa gbasara akụrụ, salicylates nwere ike ịchụpụ bilirubin na mmekorita ya na albumin ma mee ka mmepe nke bilirubin encephalopathy.

ASA na metabolites ya na-abụpụta nke akụrụ. Mgbe ị na-ewere ThromboMag na usoro dị ala, ọkara ndụ (T_½) acid plasma acetylsalicylic bụ 15-20 min, salicylic acid bụ 120-180 min. Mgbe ị na-a theụ ọgwụ ahụ na oke doses n'ihi saturation nke usoro enzymatic T_½ nwekwuo mmụba.

N’adịghị ka salicylates ndị ọzọ, ASA na-enweghị mmiri anaghị agbakọ n'ọbara ọbara mgbe ejiri ya ugboro ugboro. Site n'ịrụ ọrụ na-arụ ọrụ na nkịtị, akụrụ ga-eme ihe dị 80-100% nke natara ASA n'ime awa 24-72.

Hydroxide nke bụ akụkụ nke magnesium ThromboMag anaghị emetụta bioavailability nke ASA.

Mkparịta ụka ọgwụ ọjọọ

Mmetụta antiplatelet nke ASA belatara: colestyramine, ibuprofen, systemic glucocorticosteroids na antacids nwere magnesium na / ma ọ bụ aluminom hydroxide.

ASA na-eme ka nsonaazụ ahụ dịkwuo elu ma na-abawanye ihe ize ndụ nke egbu egbu mgbe ejiri ya na methotrexate (na -ebelata mkpụ ya na mkpụkọ ya na protein protein plasma) na valproic acid (na-esite na protein plasma).

Dị ka ndị NSAID ndị ọzọ, na usoro ọgwụgwọ dị elu, ASA nwere ike belata mmetụta dị egwu nke diuretics (na-egbochi usoro nke renal prostaglandins ma belata ọnụego filtration glomerular) na ọgwụ antihypertensive. Karịsịa, n'ihi mmachi asọmpi na njikọta nke prostacyclin njikọ, ọgwụ ahụ nwere ike belata mmetụta nke angiotensin na-agbanwe ntụgharị enzyme (ACE).

N'ihe dị ala, ASA na-akụda mmetụta nke ndị na-ahụ maka uricosuric (sulfinpyrazone, probenecid, benzbromarone), na-asọ mpi na-egbochi mkpịsị nke tubular kelic acid.

ASA na-eme ka nsonaazụ ahụ dịkwuo elu ma nwekwuo ohere nke mmetụta ndị ọzọ ọgwụ ndị a:

• ndị NSAID ndị ọzọ na ịkọ ọgwụ (n'ihi mmekọrịta nke ihe),
• carbonic anhydrase inhibitors, dịka ọmụmaatụ, acetazolamide (ọ ga - ekwe omume ịmalite nnukwu acidosis ma bulite mmetụta nsi ahụ na sistemụ etiti).
• digoxin na lithium (mwepu nke akụrụ ha na-ebelata, ihe ndọta plasma na-abawanye, ekwesịrị ilebara ndọta nke plasma anya ma dozie ọ̀hà ya mkpa)
• nhọrọ serotonin reuptake inhibitors, gụnyere paroxetine na sertraline (n'ihi ọgbụgba ọkụ synergistic, nwere nnukwu nsogbu ọbara ọgbụgba na oke eriri afọ),
• ndị na - egbochi ọgwụ mgbochi (gụnyere clopidogrel na dipyridamole), ọgwụ anticoagulants na - apụtaghị ìhè (gụnyere ticlopidine na warfarin), heparin, ọgwụ thrombolytic (n'ihi oke protein na plasma nke mmetụta ọgwụgwọ bụ isi),
• ndị nnọchianya ọgwụ hypoglycemic, nke bụ usoro nke sulfonylurea, na insulin ASA n'ọtụtụ usoro kwa ụbọchị (karịa 2000 mg) n'onwe ya nwere akụrụngwa hypoglycemic, ma na-ewepụkwa ihe nchịkọta sulfonylurea site na njikọta na protein plasma,
• sulfonamides, gụnyere co-trimoxazole (ASA na -eme ka ha ghara inwe mkparịta ụka na protein plasma ma na-abawanye itinye uche na plasma ọbara).
• ethanol (ihe ọ na-emebi na mucous akpụkpọ ahụ nke sistem na-eme ka ọ dịkwuo elu, ihe ọghọm nke ọbara ọgbụgba na-abawanye).

Analogs nke ThromboMag bụ: Cardiomagnyl, Thrombital, Thrombital Forte, Phasostabil.

Ngosiputa ogwu

Prophylaxis nke mbu nke ọrịa obi na akwara dị ka thrombosis na oke obi ọgụ na ihe ihe egwu (dịka ọmụmaatụ ọrịa shuga, hyperlipidemia, ọbara mgbali elu, oke ibu, ị smokingụ sịga, ịka nká), mgbochi nke myocardial infarction na thrombosis arịa ọbara, mgbochi nke thromboembolism mgbe ịwa ahụ. ntinye vaskụla (akwara ọbara na-agagharị agagharị, mkpụrụedemede akwara na-agafe agafe), angina pectoris ejisighi ike.

Usoro usoro onunu ogwu

A na-ewere ọgwụ ahụ n'ọnụ, 1-2 awa mgbe nri gasịrị, 1 oge / ụbọchị. E kwesịrị iji mmiri jupụta mbadamba nkume ndị ahụ. Ọ bụrụ na achọrọ, mbadamba nkume ahụ nwere ike ịgbaji na ọkara, ata ma ọ bụ tupu ebe.

O bu n'uche ogwu a ka o jiri ogologo oge. Ọ bụ dọkịta ga-ekpebi oge ọgwụgwọ ọ bụla.

Maka mgbochi mbụ nke ọrịa obi na akwara dị ka thrombosis na nnukwu obi obi na ọnụnọ ihe ọghọm (dịka ọmụmaatụ, ọrịa shuga mellitus, hyperlipidemia, ọbara mgbali akwara, oke ibu, ị smokingụ sịga, ịka nká), 1 tab. nkwadebe nwere acetylsalicylic acid na dose nke 150 mg n'ụbọchị mbụ, emesịa taabụ 1. nkwadebe nwere acetylsalicylic acid na dose 75 mg 1 oge / ụbọchị.

Maka mgbochi nke infarction myocardial ugboro ugboro yana thrombosis arịa ọbara, 1 taabụ. nkwadebe nwere Acetylsalicylic acid na dose nke 75-150 mg 1 oge / ụbọchị.

Maka mgbochi nke thromboembolism mgbe ihe gbasara ịwa ahụ na arịa (akwara akwara akwara grafting, percutaneous transluminal coronary angioplasty), 1 tab. nkwadebe nwere Acetylsalicylic acid na dose nke 75-150 mg 1 oge / ụbọchị.

Na angina ejisighi ike, 1 tab. nkwadebe nwere Acetylsalicylic acid na dose nke 75-150 mg 1 oge / ụbọchị.

Ọ bụrụ n ’ị missụ otu ọgwụ ma ọ bụ karịa atụfuo ọgwụ ahụ, ị ​​ga-anụrụ ọgwụ echefuru ozugbo onye ọrịa ahụ chetara nke a. Iji zere ịgbanye okpukpu abụọ nke ọgwụ a, ịkwesighi ị were mbadamba ihe furu efu ma ọ bụrụ na oge ị theụ ọgwụ ọzọ na-eru nso.

Achọpụtaghị ihe dị iche iche nke ị theụ ọgwụ ahụ na ọgwụ mbụ ma ọ bụ wepu ọgwụ ahụ.

Mmetụta akụkụ

N'izugbe, a na-anabata nkwadebe ndị nwere ngwakọta a.

Site na usoro ụjọ ahụ: mgbe mgbe - isi ọwụwa, nsogbu ehighị ụra, ugboro ugboro - ọgbụgba, iro ụra, adịkarịghị - tinnitus, ọbara ọgbụgba ọbara intracerebral.

Site na sistemụ hemopoietic: ọtụtụ mgbe - ọbara ọgbụgba dị ukwuu, ọ na - adịkarị obere - anaemia, ọ na - adịkarị obere - aplastic anaemia, hypoprothrombinemia, thrombocytopenia, neutropenia, leukopenia, eosinophilia, agranulocytosis. Enwere akụkọ banyere ikpe gbasara hemolysis na ọrịa hemolytic n'ime ndị ọrịa nwere oke glucose-6-phosphate dehydrogenase.

Site na usoro iku ume: ọtụtụ mgbe - bronchospasm.

Site na nri digestive: oge ​​mgbe - obi mgbawa, mgbe mgbe - ọgbụgbọ, ọgbụgbọ, infrequently - mgbu na afọ, ọnya nke mucous akpụkpọ ahụ nke afo na duodenum, ọbara ọgbụgba, adịkarịghị - perforation nke afo ọnya afọ ma ọ bụ duodenal ọnya, ụba ọrụ nke imeju enzymes , dịkarịsịrị ala - stomatitis, esophagitis, ọnya nke mbufụt nke eriri afọ nke akụkụ eriri afọ (gụnyere ya na njiri ike), ọnya afọ (copatitis), mgbaka afọ mgbu.

Mmeghachi omume nfụkasị ahụ: na - adịghị ala ala - urticaria, edebi nke Quincke, ọnya anụ ahụ, itching, rhinitis, ọrịre nke imi imi, na-adịkarịghị - ujo anafilactic, ọrịa obi na-arịa obi.

Ndị ọzọ: ọ na - adịkarịghị - arụ ọrụ ezumike n’ọrụ.